Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor

Details for Australian Patent Application No. 2004222527 (hide)

Owner Pharmacia Italia SPA

Inventors Pacciarini, Maria Adele; Suarato, Antonino; Geroni, Maria Cristina

Agent Spruson & Ferguson

Pub. Number AU-A-2004222527

PCT Pub. Number WO2004/082689

Priority 03075780.1 18.03.03 EP

Filing date 4 March 2004

Wipo publication date 30 September 2004

International Classifications

A61K 031/704

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/082689 Priority application(s): WO2004/082689

29 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222528-Stabilisation of growth hormones in solution

2004222526-Nemorubicin as radiosensitizer in combination with radiation therapy against tumors